Leeward Investments’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.7M Sell
43,835
-1,511
-3% -$409K 0.58% 76
2025
Q4
$11.4M Sell
45,346
-2,593
-5% -$689K 0.58% 75
2025
Q3
$13.8M Sell
47,939
-1,736
-3% -$465K 0.7% 52
2025
Q2
$13M Sell
49,675
-5,055
-9% -$1.23M 0.69% 56
2025
Q1
$12.7M Sell
54,730
-1,910
-3% -$463K 0.68% 65
2024
Q4
$13M Sell
56,640
-1,951
-3% -$448K 0.65% 62
2024
Q3
$13.1M Sell
58,591
-15,179
-21% -$3.34M 0.61% 65
2024
Q2
$15M Sell
73,770
-3,336
-4% -$679K 0.69% 56
2024
Q1
$16.8M Buy
77,106
+3,650
+5% +$804K 0.75% 46
2023
Q4
$16.7M Sell
73,456
-1,967
-3% -$413K 0.78% 45
2023
Q3
$15.2M Buy
75,423
+16,916
+29% +$3.57M 0.78% 45
2023
Q2
$12.1M Sell
58,507
-3,746
-6% -$727K 0.57% 87
2023
Q1
$12.3M Sell
62,253
-20,013
-24% -$4.12M 0.56% 92
2022
Q4
$16.6M Buy
82,266
+10,992
+15% +$2.15M 0.74% 55
2022
Q3
$12.5M Buy
71,274
+11,840
+20% +$2.42M 0.6% 77
2022
Q2
$12M Buy
+59,434
New +$12.7M 0.55% 83

Other funds holding LH

Leeward Investments's LH Position: Q1 2026 in Review

Leeward Investments reduced its Labcorp (LH) stake by 3.3% in Q1 2026, selling an estimated $409K and leaving 43,835 shares worth $11.7M. The position accounts for 0.58% of the portfolio, ranked #76.

Leeward Investments first reported a position in LH in Q2 2022 and has held it in 16 quarters since. The position peaked at $16.8M in Q1 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Leeward Investments held 43,835 shares of Labcorp worth $11.7M as of Q1 2026.
  • Leeward Investments sold 1,511 Labcorp shares in Q1 2026, an estimated $409K.
  • Labcorp made up 0.58% of Leeward Investments's portfolio in Q1 2026, its #76 holding.
  • Leeward Investments first reported a position in Labcorp in Q2 2022 and has held it in 16 quarters since.
  • Leeward Investments's Labcorp position peaked at $16.8M in Q1 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Leeward Investments's 13F filing for Q1 2026, filed 17 Apr 2026.